Trial intelligence / Profile preview

Clevidipine for Hypertension in Acute Brain Injury

NCT01526876Phase 4Withdrawn

Sponsor
Columbia University
Start
Nov 2011
Primary completion
Nov 2012
Modality
Small Molecules
01

Overview

A Phase 4 trial of clevidipine in hypertension (HTN), sponsored by Columbia University. Planned start Nov 2011; status: withdrawn.

02

Drugs

clevidipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01526876.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01526876.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call